PDA comments on proposed rule: supplements and other changes to an approved application. Parenteral Drug Applications.
D018795:Device Approval / Q000331:legislation & jurisprudence* / Q000592:standards; D012957:Societies, Pharmaceutical; D014481:United States; D014486:United States Food and Drug Administration